Slp2 Activators are a curated set of chemical compounds that indirectly promote the functional activity of Slp2 through a variety of signaling pathways intricately linked to mitochondrial dynamics. Compounds such as Forskolin, 8-Bromo-cAMP, and CGS 21680 elevate intracellular cAMP, which activates Protein Kinase A, leading to the phosphorylation of proteins that could enhance the interaction and function of Slp2 in mitochondrial morphology regulation. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates Protein Kinase C, another pathway that can augment Slp2's role in mitochondrial signaling and localization. Calcium signaling is also pivotal for Slp2 activation, with chemicals like Ionomycin and A23187 increasing intracellular calcium levels, and BAPTA-AM modulating it, thereby affecting Slp2's calcium-dependent mitochondrial functions. Isoproterenol, through beta-adrenergic receptors, also raises cAMP levels, further influencing Slp2's activity via phosphorylation cascades.
The activity of Slp2 is further influenced by compounds that modulate various cellular signaling pathways. Epigallocatechin gallate (EGCG) affects multiple pathways, including those linked to mitochondrial function, which could enhance Slp2's activity in regulating mitochondrial dynamics. LY294002 and U0126, by altering the PI3K/AKT and ERK/MAPK pathways respectively, could lead to modifications in mitochondrial function and localization, thereby potentiating Slp2's activity. Moreover, SRT1720, by activating SIRT1, has implications for mitochondrial biogenesis and function, suggesting a potential enhancement of Slp2's regulatory role in these processes. These activators, through their targeted effects on intracellular signaling, facilitate the enhancement of Slp2-mediated functions related to mitochondrial dynamics without the need for upregulating its expression or direct activation. Collectively, these Slp2 Activators contribute to the fine-tuning of cellular energy homeostasis by influencing the protein's activity in a network of signaling pathways that converge on the mitochondria, highlighting the complexity and interconnectivity of intracellular signaling in the regulation of mitochondrial morphology and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). Slp2 is known to associate with components of the PKC signaling pathway. Activation of PKC can enhance Slp2's role in intracellular signaling and membrane trafficking. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which subsequently activates PKA. PKA activation can phosphorylate proteins that interact with Slp2, leading to enhanced Slp2-mediated signaling processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore raising intracellular calcium levels. Elevated calcium can activate calmodulin and calcium-dependent kinases, which may phosphorylate and thereby enhance the activity of Slp2. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which can lead to downstream effects on the cytoskeleton and cellular trafficking, potentially enhancing Slp2's role in these processes. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $160.00 $750.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases can result in increased phosphorylation levels of proteins within Slp2's signaling network, enhancing Slp2 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits protein phosphatases. This leads to increased phosphorylation and potential activation of proteins that may interact with and regulate Slp2's function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG inhibits various protein kinases, potentially altering signaling pathways that include Slp2. Through such inhibition, it could shift the equilibrium in favor of Slp2's enhanced functional activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. Elevated calcium can enhance Slp2 activity indirectly through calcium-dependent signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA. PKA can then phosphorylate substrates within Slp2's signaling network, potentially enhancing Slp2's activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
This compound is a selective PKC inhibitor. By selectively inhibiting certain PKC isoforms, it may indirectly enhance the activity of Slp2 by reducing negative regulatory effects on Slp2's signaling pathways. | ||||||